Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M61,922Revenue $M21,848Net Margin (%)11.0Z-Score3.8
Enterprise Value $M62,327EPS $1.6Operating Margin %11.9F-Score7
P/E(ttm))27.2Cash Flow Per Share $6.7Pre-tax Margin (%)11.6Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %-1.3Quick Ratio1.6Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %-22.6Current Ratio1.9Lower Leverage y-yN
Price/Cash Flow9.8y-y EBITDA Growth Rate %56.7ROA % (ttm)5.6Higher Current Ratio y-yY
Dividend Yield %1.9Insider Buy (3m)0ROE % (ttm)10.1Less Shares Outstanding y-yY
Payout Ratio %52.0Shares Outstanding M1,502ROI % (ttm)9.7Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTJean-Marie Eveillard 2014-06-30 Buy 0.16%$37.02 - $41
($39.24)
$ 41.486%New holding, 1665688 sh.1,665,688
ABTGeorge Soros 2014-06-30 Reduce-0.11%$37.02 - $41
($39.24)
$ 41.486%Reduce -23.73%932,181
ABTGeorge Soros 2014-03-31 Add0.1%$35.85 - $40.12
($38.54)
$ 41.488%Add 25.97%1,222,181
ABTRay Dalio 2014-03-31 Buy 0.01%$35.85 - $40.12
($38.54)
$ 41.488%New holding, 17200 sh.17,200
ABTDaniel Loeb 2014-03-31 Sold Out -2.1%$35.85 - $40.12
($38.54)
$ 41.488%Sold Out0
ABTDaniel Loeb 2013-12-31 Buy 2.1%$33.01 - $38.71
($36.89)
$ 41.4812%New holding, 3250000 sh.3,250,000
ABTMario Gabelli 2013-12-31 Add0.02%$33.01 - $38.71
($36.89)
$ 41.4812%Add 110.21%197,183
ABTRay Dalio 2013-12-31 Sold Out -0.03%$33.01 - $38.71
($36.89)
$ 41.4812%Sold Out0
ABTPRIMECAP Management 2013-09-30 Add0.19%$32.93 - $36.88
($35.12)
$ 41.4818%Add 36.9%16,188,865
ABTRay Dalio 2013-09-30 Buy 0.03%$32.93 - $36.88
($35.12)
$ 41.4818%New holding, 118700 sh.118,700
ABTMason Hawkins 2013-09-30 Reduce-0.12%$32.93 - $36.88
($35.12)
$ 41.4818%Reduce -4.79%13,727,856
ABTJohn Hussman 2013-06-30 Sold Out -0.52%$34.88 - $38.56
($36.68)
$ 41.4813%Sold Out0
ABTVanguard Health Care Fund 2013-06-30 Reduce-0.24%$34.88 - $38.56
($36.68)
$ 41.4813%Reduce -18.79%7,591,400
ABTPRIMECAP Management 2013-03-31 Add0.23%$31.34 - $35.32
($33.84)
$ 41.4823%Add 58.55%11,683,747
ABTGeorge Soros 2013-03-31 Add0.23%$31.34 - $35.32
($33.84)
$ 41.4823%Add 93.84%1,140,752
ABTMario Gabelli 2013-03-31 Add0.01%$31.34 - $35.32
($33.84)
$ 41.4823%Add 40.97%84,215
ABTDaniel Loeb 2013-03-31 Sold Out -1.1%$31.34 - $35.32
($33.84)
$ 41.4823%Sold Out0
ABTJoel Greenblatt 2013-03-31 Sold Out -0.06%$31.34 - $35.32
($33.84)
$ 41.4823%Sold Out0
ABTMeridian Funds 2013-03-31 Sold Out -0.02%$31.34 - $35.32
($33.84)
$ 41.4823%Sold Out0
ABTMason Hawkins 2012-12-31 Add1.43%$14.4 - $16.51
($15.11)
$ 41.48174%Add 85.61%14,754,193
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABT Jean-Marie Eveillard 2014-06-301,665,6880.110.16New Buy
ABT Ray Dalio 2014-06-3017,70000.01+2.91%
ABT PRIMECAP Management 2014-06-3017,127,0631.140.77+0.23%
ABT Vanguard Health Care Fund 2014-06-307,591,4000.510.82
ABT Dodge & Cox 2014-06-3036,89800-0.14%
ABT Mason Hawkins 2014-06-3013,687,8770.913-0.43%
ABT Mario Gabelli 2014-06-30160,7070.010.03-4.62%
ABT George Soros 2014-06-30932,1810.060.29-23.73%
Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Foltz Charles DSenior Vice President 2014-03-03Sell1,588$38.956.5view
Mason Heather LSenior Vice President 2014-03-03Sell2,196$38.956.5view
Blaser Brian JExecutive Vice President 2014-03-03Sell1,441$39.016.33view
ASHLEY RICHARD WExecutive Vice President 2014-03-03Sell2,098$396.36view
ALLEN HUBERT LExecutive Vice President 2014-03-03Sell1,543$39.036.28view
Funck Robert EVice President, Controller 2014-03-03Sell1,413$38.976.44view
FREYMAN THOMAS CExecutive Vice President 2014-03-03Sell2,984$39.16.09view
Contreras JaimeSenior Vice President 2014-03-03Sell8,081$39.375.36view
Warmuth Michael JExecutive Vice President 2014-03-03Sell16,484$39.016.33view
Doyle Katherine C.Senior Vice President 2014-03-03Sell6,639$39.016.33view

Press Releases about ABT :

    Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    Sure Bets: Slow-Changing Industries for Long-Term Investors Oct 01 2014 
    Market Indicators That Could Spell Trouble for Investors Sep 29 2014 
    Medical Technology Company Offers Investment Opportunity Sep 25 2014 
    Weekly 52-Week Highs Highlight: ABT, SWK, LMT, AMGN Sep 13 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Abbott: A Brighter Future Aug 28 2014 
    6 Stocks Currently Trading Below Fair Value Jul 02 2014 
    Why I Bought Baxter International Jun 19 2014 
    Two Stocks On My Watch List For June 2014 May 29 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 


    More From Other Websites
    Abbott Goes Extra Mile in Commitment to Helping People Live Healthy Lives as an Official Sponsor of... Oct 01 2014
    Abbott Labs Completes CFR Pharmaceuticals Acquisition Oct 01 2014
    Abbott Hosts Conference Call for Third-Quarter Earnings Oct 01 2014
    ABBOTT LABORATORIES Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Sep 26 2014
    Abbott Completes Acquisition of CFR Pharmaceuticals; Announces Results of Tender Offer for CFR... Sep 26 2014
    Abbott, AbbVie win dismissal of claims over Humira, AndroGel Sep 25 2014
    Ex-Advanced Medical Optics CEO Indicted in Insider Case Sep 24 2014
    Expiration of the U.S. Tender Offer for CFR Pharmaceuticals S.A. Sep 24 2014
    Never Mind What Lew or Bill Clinton or Camp Say: Opening Line Sep 24 2014
    [video] Tax crackdown impact on pharma deals Sep 23 2014
    [video] Treasury Secretary Jacob Lew Unveils Steps to Curb Tax Inversions Sep 23 2014
    India's withdrawal of drug price cap guidelines to be on prospective basis Sep 23 2014
    India withdraws regulator's power to cap non-essential drug prices Sep 23 2014
    [video] China very important for world growth: Cramer Sep 22 2014
    China very important for world growth: Cramer Sep 22 2014
    Today's Market Thorns, Roses, and All Time Highs... Sep 19 2014
    Abbott Included In Top 10 Best Companies by Working Mother Magazine Sep 16 2014
    The Keys In This Market: Income & Growth Sep 16 2014
    Abbott Labs Presents Positive One-Year Data on Absorb Sep 15 2014
    Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart... Sep 15 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK